Introduction: This review evaluates the potential of glucagon‑like peptide‑1 receptor agonists (GLP‑1RAs) - first developed for type 2 diabetes and later approved for chronic weight management - to be repurposed as neuroprotec... ...

请注册登录后继续浏览